About 1 million Americans suffer from Parkinson's disease, with around 90,000 new cases diagnosed each year, according to the ...

The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.

The Michael J. Fox Foundation for Parkinson's Research marks the eighth year of its Parkinson's IQ + You national event series, traveling across the United States to educate and empower people and ...

Scientists have identified the role of an ion channel that plays a key part in how cells break down and recycle components, a ...

Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the striatum may improve the efficacy of a first-line therapy for Parkinson's ...

Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...

The FDA has granted Regenerative Medicine Advanced Therapy designation to NouvNeu001, a cell therapy for Parkinson’s disease. NouvNeu001, developed by iRegene, is the first allogeneic cell therapy ...

Korean researchers say this common bacterium's journey throughout the body could lead to consequences in the brain.

Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

In people with Parkinson's disease, dysphagia is usually treated first with medicines that aim to improve the symptoms of Parkinson’s disease overall. If swallowing problems continue, rehabilitation ...

For more than 200 years, ever since a British apothecary named James Parkinson in 1817 published “An Essay on the Shaking Palsy,” scientists have searched for the reasons why some people develop ...